Cita APA

Fullerton, T., Binneman, B., David, W., Delnomdedieu, M., Kupiec, J., Lockwood, P., . . . Bell, J. (2018). A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil. Alzheimers Res Ther.

Citación estilo Chicago

Fullerton, Terence, Brendon Binneman, William David, Marielle Delnomdedieu, James Kupiec, Peter Lockwood, Jessica Mancuso, Jeffrey Miceli, y Joanne Bell. "A Phase 2 Clinical Trial of PF-05212377 (SAM-760) in Subjects With Mild to Moderate Alzheimer’s Disease With Existing Neuropsychiatric Symptoms On a Stable Daily Dose of Donepezil." Alzheimers Res Ther 2018.

Cita MLA

Fullerton, Terence, et al. "A Phase 2 Clinical Trial of PF-05212377 (SAM-760) in Subjects With Mild to Moderate Alzheimer’s Disease With Existing Neuropsychiatric Symptoms On a Stable Daily Dose of Donepezil." Alzheimers Res Ther 2018.